RESUMEN
The liver is the principal source of glutamate in blood plasma. Recently we have discovered that efflux of glutamate from hepatocytes is catalyzed by the transporter OAT2 (human gene symbol SLC22A7). Organic anion transporter 2 (OAT2) is an integral membrane protein of the sinusoidal membrane domain; it is primarily expressed in liver and much less in kidney, both in rats and humans. Many years ago, Häussinger and coworkers have demonstrated in isolated perfused rat liver that benzoic acid or specific 2-oxo acid analogs of amino acids like e.g. 2-oxo-4-methyl-pentanoate ('2-oxo-leucine') strongly stimulate release of glutamate (up to 7-fold); '2-oxo-valine' and the corresponding amino acids were without effect. The molecular mechanism of efflux stimulation has remained unclear. In the present study, OAT2 from human and rat were heterologously expressed in 293 cells. Addition of 1 mmol/l benzoic acid to the external medium increased OAT2-specific efflux of glutamate up to 20-fold; '2-oxo-leucine' was also effective, but not '2-oxo-valine'. Similar effects were seen for efflux of radiolabeled orotic acid. Expression of OAT2 did not increase uptake of benzoic acid; thus, benzoic acid is no substrate, and trans-stimulation can be excluded. Instead, further experiments suggest that increased efflux of glutamate is caused by direct interaction of benzoic acid and specific 2-oxo acids with OAT2. We propose that stimulators bind to a distinct extracellular site and thereby accelerate relocation of the empty substrate binding site to the intracellular face. Increased glutamate efflux at OAT2 could be the main benefit of benzoate treatment in patients with urea cycle defects.
Asunto(s)
Ácidos/química , Ácido Benzoico/farmacología , Ácido Glutámico/metabolismo , Hígado/metabolismo , Transportadores de Anión Orgánico Sodio-Independiente/metabolismo , Animales , Ácido Benzoico/química , Sitios de Unión , Transporte Biológico , Relación Dosis-Respuesta a Droga , Células HEK293 , Humanos , Riñón/metabolismo , Ligandos , Ratones , Modelos Biológicos , Ratas , Especificidad por Sustrato , Factores de Tiempo , Valina/químicaRESUMEN
BACKGROUND: Structural changes in modern mining industry increase the potential for medical emergencies. Furthermore, rescue times in mining are prolonged and public medical resources are not consistently available. OBJECTIVES: We sought to train mine rescue brigade lay people to cover medical emergencies in mining. MATERIALS AND METHODS: A standardized tactical-medical approach including specific equipment was developed and taught in a didactically optimized way in 16 lessons. Objective Structured Practical Examinations (OSPE) were conducted in 3 groups of 4 mine rescue personnel and compared to the identical exam of the reference group (17 paramedics of different educational and experience levels). RESULTS: The tactical-medical scheme includes vital functions and body checks, advanced life support, nasal and intraosseous drug administration, airway management, thoracocentesis, bleeding control, tourniquet, fracture repositioning, splinting and transport bedding. In OSPE evaluation, the scores of the trained mine rescue personnel (mean [M]â¯= 3.42, 95% confidence interval [CI95%]â¯= [3.24; 3.60]) were statistically equal to those of advanced paramedics (Mâ¯= 3.28, CI95%â¯= [3.09; 3.46]), but much better than basic German paramedic level (Mâ¯= 2.43, CI95%â¯= [2.10; 2.77]). Competency retention of mine rescue personnel remained on the same level after a period of 6 months without further training (Mâ¯= 3.54, CI95%â¯= [3.31; 3.73]). CONCLUSION: The competency level after the Tactical Mining Rescue Course is comparable to the advanced paramedics level in the spectrum of competencies addressed. Medical lay people can be trained to deliver an acceptable treatment level within a clearly defined treatment algorithm, and thus potentially close the gap towards professional medical emergency rescue in mining.
Asunto(s)
Servicios Médicos de Urgencia , Auxiliares de Urgencia , Técnicos Medios en Salud , Curriculum , Urgencias Médicas , Auxiliares de Urgencia/educación , Humanos , MineríaRESUMEN
Background: Tachycardia, cardiac hypertrophy, and elevated body temperature are major signs of systemic hyperthyroidism, which are considered to reflect the excessive thyroid hormone (TH) action in the respective peripheral tissues. However, recent observations indicate that the central actions of TH also contribute substantially to cardiovascular regulation and thermogenesis. Methods: In this study, we dissect the individual contributions of peripheral TH action versus the central effects in body temperature regulation and cardiovascular functions by taking advantage of mice lacking the TH transporters monocarboxylate transporter 8 (MCT8) and organic anion transporting polypeptide 1C1 (OATP1C1) (M/O double knock-out [dko]), which exhibit elevated serum triiodothyronine (T3) levels while their brain is in a profoundly hypothyroid state. We compared these animals with wild-type (WT) mice that were treated orally with T3 to achieve similarly elevated serum T3 levels, but are centrally hyperthyroid. For the studies, we used radiotelemetry, infrared thermography, gene expression profiling, Western blot analyses, and enzyme linked immunosorbent assays (ELISA) assays. Results: Our analyses revealed mild hyperthermia and cardiac hypertrophy in T3-treated WT mice but not in M/O dko animals, suggesting that central actions of TH are required for these hyperthyroid phenotypes. Although the average heart rate was unaffected in either model, the M/O dko exhibited an altered heart rate frequency distribution with tachycardic bursts in active periods and bradycardic episodes during resting time, demonstrating that the stabilization of heart rate by the autonomic nervous system can be impaired in centrally hypothyroid animals. Conclusions: Our studies unravel distinct phenotypical traits of hyperthyroidism that depend on an intact central nervous system, and provide valuable insight into the cardiovascular pathology of the Allan-Herndon-Dudley syndrome, a condition caused by the lack of MCT8 in humans.
Asunto(s)
Cardiomegalia/metabolismo , Fiebre/metabolismo , Frecuencia Cardíaca , Hipotiroidismo/complicaciones , Hormonas Tiroideas/metabolismo , Animales , Cardiomegalia/prevención & control , Cruzamientos Genéticos , Ensayo de Inmunoadsorción Enzimática , Perfilación de la Expresión Génica , Glucógeno/metabolismo , Lipólisis , Hígado/metabolismo , Masculino , Discapacidad Intelectual Ligada al Cromosoma X/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Transportadores de Ácidos Monocarboxílicos/genética , Hipotonía Muscular/metabolismo , Atrofia Muscular/metabolismo , Fenotipo , Telemetría , Termogénesis , Termografía , Factores de Tiempo , Triyodotironina/sangreRESUMEN
INTRODUCTION: Injection of 3-iodothyronamine into experimental animals profoundly affects their metabolism and body temperature. As 3-iodothyronamine is rapidly acetylated in vivo after injection, it was hypothesized that the metabolites N- or O-acetyl-3-iodothyronamines could constitute the active hormones. METHODS: Adult male mice were injected once daily with one of the metabolites (5 mg/kg body weight intraperitoneally dissolved in 60% DMSO in PBS) or solvent. Metabolism was monitored by indirect calorimetry, body temperature by infrared thermography, and body composition by nuclear magnetic resonance analysis. Signaling activities in brown fat or liver were assessed by studying target gene transcription by qPCR including uncoupling protein 1 or deiodinase type 1 or 2, and Western blot. RESULTS: The markers of metabolism, body composition, or temperature tested were similar in the mice injected with solvent and those injected with one of the acetylated 3-iodothyronamines. CONCLUSIONS: In our experimental setup, N- and O-acetyl-3-iodothyronamine do not constitute compounds contributing to the metabolic or temperature effects described for 3-iodothyronamine. The acetylation of 3-iodothyronamine observed in vivo may thus rather serve degradation and elimination purposes.
RESUMEN
Environmental temperature is a driving factor in evolution, and it is commonly assumed that metabolic adaptations to cold climates are the result of transgenerational selection. Here, we show in mice that even minor changes in maternal thermogenesis alter the metabolic phenotype already in the next generation. Male offspring of mothers genetically lacking brown adipose tissue (BAT) thermogenesis display increased lean mass and improved glucose tolerance as adults, while females are unaffected. The phenotype is replicated in offspring of mothers kept at thermoneutrality; conversely, mothers with higher gestational BAT thermogenesis produce male offspring with reduced lean mass and impaired glucose tolerance. Running-wheel exercise reverses the offspring's metabolic impairments, pointing to the muscle as target of these fetal programming effects. Our data demonstrate that gestational BAT activation negatively affects metabolic health of the male offspring; however, these unfavorable fetal programming effects may be negated by active lifestyle.
Asunto(s)
Tejido Adiposo Pardo/fisiología , Glucosa/metabolismo , Termogénesis/fisiología , Animales , Metabolismo Energético/fisiología , Femenino , Homeostasis , Humanos , Masculino , Metabolómica , Ratones Endogámicos C57BL , Ratones Noqueados , Fenotipo , Condicionamiento Físico Animal , Embarazo , Temperatura , Proteína Desacopladora 1/deficiencia , Proteína Desacopladora 1/metabolismoRESUMEN
Stimulation of thermogenic pathways appears to be a promising approach to find new ways of tackling metabolic diseases like obesity and diabetes mellitus type 2. Thermogenic, weight reducing and insulin sensitizing effects of phosphodiesterase 5 (PDE 5) inhibitors have recently been postulated, suggesting that modulators of endogenous cGMP signaling have the therapeutic potential to treat metabolic disorders. However, most studies have been performed in vitro or in animals that were not glucose intolerant. We, thus, aimed to test the metabolic effects of the PDE 5 inhibitor sildenafil by treating diet-induced obese (DIO) mice orally for 8 days. Surprisingly, our results revealed no changes in body temperature, brown adipose tissue (BAT) thermogenesis and gene expression in BAT and inguinal white adipose tissue (iWAT), thus excluding a thermogenic or 'browning' effect of sildenafil in preexisting obesity. In contrast, sildenafil-treated DIO mice displayed changes in liver metabolism and glucose homeostasis resulting in impaired glucose tolerance (P < 0.05), demonstrating for the first time an unfavorable metabolic effect of increased hepatic cGMP signaling in obesity. As sildenafil is commonly prescribed to treat pulmonary arterial hypertension and erectile dysfunction in diabetic and/or obese patients, follow up studies are urgently required to re-evaluate the drug safety.
Asunto(s)
Tejido Adiposo/efectos de los fármacos , Glucemia/metabolismo , Intolerancia a la Glucosa/inducido químicamente , Hígado/efectos de los fármacos , Obesidad/metabolismo , Citrato de Sildenafil/efectos adversos , Termogénesis/efectos de los fármacos , Tejido Adiposo/metabolismo , Tejido Adiposo Pardo/efectos de los fármacos , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Blanco/efectos de los fármacos , Tejido Adiposo Blanco/metabolismo , Animales , GMP Cíclico/metabolismo , Disfunción Eréctil/tratamiento farmacológico , Intolerancia a la Glucosa/sangre , Homeostasis , Hipertensión/tratamiento farmacológico , Hígado/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones Obesos , Obesidad/tratamiento farmacológico , Inhibidores de Fosfodiesterasa 5/efectos adversos , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Transducción de Señal , Citrato de Sildenafil/uso terapéuticoRESUMEN
OBJECTIVE: Maternal and environmental factors control the epigenetic fetal programming of the embryo, thereby defining the susceptibility for metabolic or endocrine disorders in the offspring. Pharmacological interventions required as a consequence of gestational problems, e.g. hypertension, can potentially interfere with correct fetal programming. As epigenetic alterations are usually only revealed later in life and not detected in studies focusing on early perinatal outcomes, little is known about the long-term epigenetic effects of gestational drug treatments. We sought to test the consequences of maternal α1-adrenergic antagonism during pregnancy, which can occur e.g. during hypertension treatment, for the endocrine and metabolic phenotype of the offspring. METHODS: We treated C57BL/6NCrl female mice with the α1-adrenergic antagonist prazosin during pregnancy and analyzed the male and female offspring for endocrine and metabolic abnormalities. RESULTS: Our data revealed that maternal α1-adrenergic blockade caused dwarfism, elevated body temperature, and insulin resistance in male offspring, accompanied by reduced IGF-1 serum concentrations as the result of reduced hepatic growth hormone receptor (Ghr) expression. We subsequently identified increased CpG DNA methylation at the transcriptional start site of the alternative Ghr promotor caused by the maternal treatment, which showed a strong inverse correlation to hepatic Ghr expression. CONCLUSIONS: Our results demonstrate that maternal α1-adrenergic blockade can constitute an epigenetic cause for dwarfism and insulin resistance. The findings are of immediate clinical relevance as combined α/ß-adrenergic blockers are first-line treatment of maternal hypertension.
Asunto(s)
Enanismo/etiología , Prazosina/efectos adversos , Tejido Adiposo Pardo/metabolismo , Antagonistas de Receptores Adrenérgicos alfa 1/efectos adversos , Antagonistas de Receptores Adrenérgicos alfa 1/metabolismo , Animales , Animales Recién Nacidos , Enanismo/metabolismo , Epigénesis Genética/efectos de los fármacos , Femenino , Desarrollo Fetal/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Resistencia a la Insulina/fisiología , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Hígado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Prazosina/farmacología , Embarazo , Efectos Tardíos de la Exposición Prenatal/metabolismo , Receptores de Somatotropina/genética , Termogénesis/efectos de los fármacosRESUMEN
DEFINITION OF THE PROBLEM: There is an increasing demand for invasive forms of cosmetic surgery. In view of the omnipresent confrontation with some idealized standards of beauty in advertising, films, beauty-shows etc., this paper deals with the question of whether women undergo cosmetic surgery because they are forced by a norm-setting beauty system or whether they choose these operations themselves. ARGUMENTS: I offer an analysis of what could be an adequate concept of autonomous choice in this area. Particularly, it will be shown that a libertarian concept of autonomy is inadequate for analyzing the moral status of cosmetic surgery. CONCLUSION: A concept of autonomy is outlined that enables us to qualify certain kinds of pressure as autonomy restricting.
Asunto(s)
Autonomía Personal , Cirugía Plástica/ética , Belleza , Imagen Corporal , Coerción , Femenino , Humanos , Motivación , MujeresRESUMEN
Inherited mtDNA mutations cause severe human disease. In most species, mitochondria are inherited maternally through mechanisms that are poorly understood. Genes that specifically control the inheritance of mitochondria in the germline are unknown. Here, we show that the long isoform of the protein Oskar regulates the maternal inheritance of mitochondria in Drosophila melanogaster. We show that, during oogenesis, mitochondria accumulate at the oocyte posterior, concurrent with the bulk streaming and churning of the oocyte cytoplasm. Long Oskar traps and maintains mitochondria at the posterior at the site of primordial germ cell (PGC) formation through an actin-dependent mechanism. Mutating long oskar strongly reduces the number of mtDNA molecules inherited by PGCs. Therefore, Long Oskar ensures germline transmission of mitochondria to the next generation. These results provide molecular insight into how mitochondria are passed from mother to offspring, as well as how they are positioned and asymmetrically partitioned within polarized cells.
Asunto(s)
Proteínas de Drosophila/genética , Drosophila melanogaster/genética , Genes de Insecto , Genes Mitocondriales/genética , Actinas/metabolismo , Animales , Variaciones en el Número de Copia de ADN , ADN Mitocondrial/genética , ADN Mitocondrial/metabolismo , Drosophila melanogaster/embriología , Drosophila melanogaster/metabolismo , Células Germinales Embrionarias/metabolismo , Femenino , Humanos , Oogénesis/genética , Isoformas de Proteínas/genéticaRESUMEN
Brown adipose tissue (BAT) dissipates nutritional energy as heat via the uncoupling protein-1 (UCP1) and BAT activity correlates with leanness in human adults. Here we profile G protein-coupled receptors (GPCRs) in brown adipocytes to identify druggable regulators of BAT. Twenty-one per cent of the GPCRs link to the Gq family, and inhibition of Gq signalling enhances differentiation of human and murine brown adipocytes. In contrast, activation of Gq signalling abrogates brown adipogenesis. We further identify the endothelin/Ednra pathway as an autocrine activator of Gq signalling in brown adipocytes. Expression of a constitutively active Gq protein in mice reduces UCP1 expression in BAT, whole-body energy expenditure and the number of brown-like/beige cells in white adipose tissue (WAT). Furthermore, expression of Gq in human WAT inversely correlates with UCP1 expression. Thus, our data indicate that Gq signalling regulates brown/beige adipocytes and inhibition of Gq signalling may be a novel therapeutic approach to combat obesity.